Literature DB >> 8022107

Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.

E Muso1, M Yashiro, Y Ito, H Yoshida, S Sasayama.   

Abstract

The serum levels of circulating immune complexes (CIC) measured by three different types of enzyme immunoassay (EIA) using monoclonal anti-C1q and antibodies and C1q as solid phase reagents were compared with clinical disease activity and immunohistological glomerular lesions in 29 SLE patients. Three types of CIC measured by these assays (anti-C1q CIC, anti-C3d CIC and C1q SP CIC) showed significantly higher levels in patients than in controls and were significantly associated with the clinical and serological disease activities. Anti-C1q CIC showed good correlation not only with mesangial IgG depositions (P < 0.01), but also with that of C1q (P < 0.05). C1q SP CIC also showed a weak correlation with mesangial C1q deposition (P < 0.05). Serum levels of anti-C3d CIC increased with the degree of mesangial IgG and complement depositions. Analysis of the clinical course of a patient with active SLE revealed a more rapid decrease of anti-C1q CIC and anti-C3d CIC along with the improvement of disease activity, including the mesangial lesion, than that of C1q SP CIC. According to these results, the CIC detected with assays using monoclonal antibodies against complement fragments, especially the anti-C1q assay, is likely to provide specific information regarding the clinical, serological and immunohistological disease activity in lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022107

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  2 in total

1.  Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus.

Authors:  Qingjun Pan; Linjie Guo; Jing Wu; Jun Cai; Huanjin Liao; Qiaofen Lan; Yanxia Peng; Yiming He; Hua-Feng Liu
Journal:  Mediators Inflamm       Date:  2016-08-11       Impact factor: 4.711

2.  IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.

Authors:  Qingjun Pan; Haiyan Xiao; Lei Shi; Yiming He; Jun Cai; Jing Wu; Aifen Li; Lin Ye; Chen Yang; Hua-Feng Liu
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.